MedTrace Logo

Immunological Response After Shrimp Oral Immunotherapy Treatment

NCT04552522 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2026-04-03

Study results available
· View outcomes & findings →

Summary

Oral immunotherapy is effective in desensitized food allergy. Shrimp allergy is increasing in Thailand. So the purpose of our study is to determine level of specific immunoglobulin E antibodies to shrimp, Immunoglobulin G4 and immunoblot analysis in shrimp allergy patients after shrimp oral immunotherapy.

Conditions

  • Allergy to Shrimp
  • Immunotherapy

Interventions

OTHER

shrimp allergy with intend to eat shrimp

shrimp allergy with intend to eat shrimp and treat with oral immunotherapy

Sponsors & Collaborators

  • Mahidol University

    lead OTHER

Principal Investigators

  • Punchama Pacharn, MD · Mahidol University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-28
Primary Completion
2024-10-31
Completion
2024-12-30

Countries

  • Thailand

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04552522 on ClinicalTrials.gov